Advanced search
Publication Cover
International Journal of Psychiatry in Clinical Practice Volume 16, 2012 - Issue 2
Submit an article Journal homepage
179
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Several prescription patterns of antipsychotic drugs influence cognitive functions in Japanese chronic schizophrenia patients

Hikaru HoriDepartment of Psychiatry, University of Occupational and Environmental Health Japan, School of Medicine, Kitakyushu, JapanCorrespondence[email protected]
,
Reiji YoshimuraDepartment of Psychiatry, University of Occupational and Environmental Health Japan, School of Medicine, Kitakyushu, Japan
,
Asuka KatsukiDepartment of Psychiatry, University of Occupational and Environmental Health Japan, School of Medicine, Kitakyushu, Japan
,
Kenji HayashiDepartment of Psychiatry, University of Occupational and Environmental Health Japan, School of Medicine, Kitakyushu, Japan
,
Atsuko Ikenouchi-SugitaDepartment of Psychiatry, University of Occupational and Environmental Health Japan, School of Medicine, Kitakyushu, Japan
,
Wakako Umene-NakanoDepartment of Psychiatry, University of Occupational and Environmental Health Japan, School of Medicine, Kitakyushu, Japan
&
Jun NakamuraDepartment of Psychiatry, University of Occupational and Environmental Health Japan, School of Medicine, Kitakyushu, Japan
 show all
Pages 138-142 | Received 21 Jun 2011, Accepted 26 Sep 2011, Published online: 05 Dec 2011

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Phillip Pierce, Srihari Gopal, Adam Savitz, Hong Qiu, Takahito Hino, Michelle Busch, Akiko Fujino, Maju Mathews, Takeshi Katsu, Yoshikazu Maeda, Masayoshi Takahashi & David Hough. (2016) Paliperidone palmitate: Japanese postmarketing mortality results in patients with schizophrenia. Current Medical Research and Opinion 32:10, pages 1671-1679.
Read now

Articles from other publishers (18)

Junhee Lee, Sanghoon Oh, Sun-Young Moon, Silvia Kyungjin Loh, Minah Kim, Tae Young Lee & Jun Soo Kwon. (2023) Impact of long-acting injectable aripiprazole on the concomitant medication and antipsychotic polypharmacy: a retrospective, observational study of 127 patients with psychosis. International Clinical Psychopharmacology.
Crossref
Yumi Aoki, Yoshikazu Takaesu, Kentaro Matsui, Takahiro Tokumasu, Hideaki Tani, Yoshiteru Takekita, Tetsufumi Kanazawa, Taishiro Kishimoto, Seiichiro Tarutani, Naoki Hashimoto, Hiroyoshi Takeuchi, Kazuo Mishima & Ken Inada. (2023) Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia. Neuropsychopharmacology Reports.
Crossref
Chadia Haddad, Pascale Salameh, Hala Sacre, Jean-Pierre Clément & Benjamin Calvet. (2023) Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia. BMC Psychiatry 23:1.
Crossref
Hikaru Hori, Kiyokazu Atake, Asuka Katsuki & Reiji Yoshimura. (2020) Effects of the number of hospitalizations on cognitive function in Japanese patients with stable schizophrenia. CNS Spectrums 26:6, pages 658-663.
Crossref
Jung-Jin Kim, Chi-Un Pae, Changsu Han, Won-Myong Bahk, Soo-Jung Lee, Ashwin A. Patkar & Prakash S. Masand. (2021) Exploring Hidden Issues in the Use of Antipsychotic Polypharmacy in the Treatment of Schizophrenia. Clinical Psychopharmacology and Neuroscience 19:4, pages 600-609.
Crossref
Nozomi Nakajima, Nao Mizoe, Fuminari Misawa, Toru Yamashita, Ryuhei So, Kohei Kitagawa, Kenichi Tanimoto, Yoshiki Kishi, Yasuo Fujii & Hiroyoshi Takeuchi. (2020) Longitudinal changes in antipsychotic dose in patients treated with long-acting injectable second-generation antipsychotics. International Clinical Psychopharmacology 36:2, pages 84-88.
Crossref
Nicolas Coustals, Catherine Martelli, Marine Brunet-Lecomte, Amélie Petillion, Bruno Romeo & Amine Benyamina. (2020) Chronic smoking and cognition in patients with schizophrenia: A meta-analysis. Schizophrenia Research 222, pages 113-121.
Crossref
Hideaki Tani, Shotaro Takasu, Hiroyuki Uchida, Takefumi Suzuki, Masaru Mimura & Hiroyoshi Takeuchi. (2019) Factors associated with successful antipsychotic dose reduction in schizophrenia: a systematic review of prospective clinical trials and meta-analysis of randomized controlled trials. Neuropsychopharmacology 45:5, pages 887-901.
Crossref
Chi-Un Pae. (2020) Antipsychotic Polypharmacy in Treatment of Schizophrenia; Should or Should Not?. Chonnam Medical Journal 56:3, pages 157.
Crossref
M. M. Popov, I. V. Pluzhnikov & V. G. Kaleda. (2019) Procognitive effects of transcranial magnetic stimulation in the light of neurocognitive deficit in schizophrenia. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 119:3, pages 120.
Crossref
D.Y. Park, H. Song, J. Choi, S.H. Kang, J.I. Lee & W.H. Lee. (2019) Cognitive effects of second-generation antipsychotic polypharmacy in stabilized patients with schizophrenia. European Neuropsychopharmacology 29, pages S403-S404.
Crossref
Marianna Mazza, Giuseppe Marano, Gianandrea Traversi, Salvatore Mazza & Luigi Janiri. 2019. Omega Fatty Acids in Brain and Neurological Health. Omega Fatty Acids in Brain and Neurological Health 275 294 .
Kiyokazu Atake, Tomoyuki Nakamura, Nobuhisa Ueda, Hikaru Hori, Asuka Katsuki & Reiji Yoshimura. (2018) The Impact of Aging, Psychotic Symptoms, Medication, and Brain-Derived Neurotrophic Factor on Cognitive Impairment in Japanese Chronic Schizophrenia Patients. Frontiers in Psychiatry 9.
Crossref
鹏 程. (2018) The Different Effects of Antipsychotic Drugs on Cognitive Function in Adulthood and Adolescence. Advances in Psychology 08:10, pages 1452-1465.
Crossref
Kazumi Satogami, Shun Takahashi, Shinichi Yamada, Satoshi Ukai & Kazuhiro Shinosaki. (2017) Omega-3 fatty acids related to cognitive impairment in patients with schizophrenia. Schizophrenia Research: Cognition 9, pages 8-12.
Crossref
Taro Kishi, Yasuhisa Fukuo, Masatsugu Moriwaki, Nakao Iwata, Hikaru Hori, Reiji Yoshimura, Asuka Katsuki, Atsuko Ikenouchi-Sugita, Kiyokazu Atake, Wakako Umene-Nakano, Jun Nakamura, Yasuhiro Kaneda & Kiyoshi Fujita. (2014) No significant association between brain-derived neurotrophic factor gene rs6265 and cognitive function in Japanese patients with schizophrenia. Psychiatry Research 215:3, pages 803-805.
Crossref
Hikaru Hori, Reiji Yoshimura, Asuka Katsuki, Atsuko-Ikenouchi Sugita, Kiyokazu Atake & Jun Nakamura. (2013) Switching to antipsychotic monotherapy can improve attention and processing speed, and social activity in chronic schizophrenia patients. Journal of Psychiatric Research 47:12, pages 1843-1848.
Crossref
Dimitrios Kontis & Eirini Theochari. 2013. Polypharmacy in Psychiatry Practice, Volume I. Polypharmacy in Psychiatry Practice, Volume I 75 105 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.